Evidence map›Paper›PMID 35274061›Full record

ArticleProgress in rehabilitation medicine2022

Cancer Rehabilitation Provided by Designated Cancer Hospitals in Japan: The Current State of Outpatient Setting and Coordination after Discharge.

Takuya Fukushima, Tetsuya Tsuji, Noriko Watanabe, Takuro Sakurai, Aiko Matsuoka St, Kazuhiro Kojima St, Sachiko Yahiro, Mami Oki, Yusuke Okita, Shota Yokota and 10 more

Abstract read
In one paragraph

Article in Progress in rehabilitation medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Takuya FukushimaDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
Tetsuya TsujiDepartment of Rehabilitation Medicine, Keio University School of Medicine, Tokyo, Japan.
Noriko WatanabeDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
Takuro SakuraiDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
Aiko Matsuoka StDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
Kazuhiro Kojima StDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
Sachiko YahiroDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
Mami OkiDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
Yusuke OkitaDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
Shota YokotaDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.
Jiro NakanoDepartment of Physical Medicine and Rehabilitation, Kansai Medical University, Osaka, Japan.
Shinsuke SugiharaDepartment of Orthopedic Oncology and Rehabilitation, National Hospital Organization Shikoku Cancer Center, Ehime, Japan.
Hiroshi SatoDepartment of Gastroenterological Surgery, Saitama International Medical Center, Saitama Medical University, Saitama, Japan.
Juichi KawakamiDepartment of Rehabilitation Medicine, Shiga Prefectural Rehabilitation Center, Shiga, Japan.
Hitoshi KagayaDepartment of Rehabilitation Medicine I, School of Medicine, Fujita Health University, Aichi, Japan.
Akira TanumaDepartment of Rehabilitation Medicine, Juntendo University Shizuoka Hospital, Shizuoka, Japan.
Ryuichi SekineDepartment of Pain and Palliative Care, Kameda Medical Center, Chiba, Japan.
Keita MoriDepartment of Clinical Research Center, Shizuoka Cancer Center, Shizuoka, Japan.
Sadamoto ZendaDepartment of Radiation Oncology, National Cancer Center Hospital East, Chiba, Japan.
Akira KawaiDepartment of Musculoskeletal Oncology and Rehabilitation, National Cancer Center Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: The aim of the present study was to clarify the current state of outpatient cancer rehabilitation and coordination systems provided by designated cancer hospitals in Japan. Methods: A questionnaire was sent to 427 designated cancer hospitals in Japan to investigate the status of outpatient cancer rehabilitation and whether it was sufficiently conducted. The status of regional coordination with post-discharge rehabilitation facilities was surveyed. Results: Responses were received from 235/427 facilities (55.0%). Outpatient cancer rehabilitation was implemented in 92 (39.1% of responding facilities), and of these facilities, 83.7% answered that the provision of rehabilitation was insufficient. The reasons were ineligibility for reimbursement of medical fees, a lack of human resources, a lack of awareness of the need, and a lack of education. Regional coordination was conducted by 39.1% of responding facilities, yet a regional alliance path had been established in only 9.8% of centers. The absence of coordination was associated with large facility size, the absence of physiatrists, and few rehabilitation professionals who had completed the training program; an insufficient framework for regional coordination was also given as a reason. Conclusions: To provide adequate outpatient cancer rehabilitation, sufficient human resources, the reimbursement of medical fees in the outpatient setting, and education and a framework to promote regional coordination are necessary.

Indexed as

cancer rehabilitationeducationoutpatientregional alliance pathrehabilitation professionals

Identifiers

PMID35274061
PMCPMC8850184

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.